Washington Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-38
| Closed | -$24.1K | – | 603 |
|
|
2025
Q1 | $24.1K | Sell |
38
-2
| -5% | -$1.27K | ﹤0.01% | 501 |
|
|
2024
Q4 | $28.5K | Sell |
40
-300
| -88% | -$214K | ﹤0.01% | 526 |
|
|
2024
Q3 | $357K | Sell |
340
-2
| -0.6% | -$2.1K | 0.01% | 230 |
|
|
2024
Q2 | $359K | Hold |
342
| – | – | 0.01% | 229 |
|
|
2024
Q1 | $329K | Hold |
342
| – | – | 0.01% | 233 |
|
|
2023
Q4 | $300K | Buy |
342
+2
| +0.6% | +$1.76K | 0.01% | 235 |
|
|
2023
Q3 | $280K | Buy |
340
+1
| +0.3% | +$823 | 0.01% | 218 |
|
|
2023
Q2 | $244K | Buy |
339
+2
| +0.6% | +$1.44K | 0.01% | 237 |
|
|
2023
Q1 | $277K | Hold |
337
| – | – | 0.01% | 228 |
|
|
2022
Q4 | $243K | Sell |
337
-1
| -0.3% | -$721 | 0.01% | 233 |
|
|
2022
Q3 | $233K | Hold |
338
| – | – | 0.01% | 224 |
|
|
2022
Q2 | $200K | Hold |
338
| – | – | 0.01% | 246 |
|
|
2022
Q1 | $236K | Buy |
338
+300
| +789% | +$209K | 0.01% | 244 |
|
|
2021
Q4 | $24K | Sell |
38
-34,297
| -100% | -$21.7M | ﹤0.01% | 552 |
|
|
2021
Q3 | $20.8M | Buy |
34,335
+772
| +2% | +$467K | 0.59% | 47 |
|
|
2021
Q2 | $18.7M | Buy |
33,563
+1,423
| +4% | +$795K | 0.53% | 58 |
|
|
2021
Q1 | $15.2M | Buy |
32,140
+6,097
| +23% | +$2.88M | 0.47% | 72 |
|
|
2020
Q4 | $12.6M | Buy |
26,043
+952
| +4% | +$460K | 0.41% | 82 |
|
|
2020
Q3 | $14M | Sell |
25,091
-590
| -2% | -$330K | 0.52% | 65 |
|
|
2020
Q2 | $16M | Sell |
25,681
-5,021
| -16% | -$3.13M | 0.67% | 39 |
|
|
2020
Q1 | $15M | Buy |
30,702
+1,203
| +4% | +$587K | 0.71% | 37 |
|
|
2019
Q4 | $11.1M | Buy |
+29,499
| New | +$11.1M | 0.44% | 80 |
|
|
2018
Q3 | – | Sell |
-231
| Closed | -$80K | – | 667 |
|
|
2018
Q2 | $80K | Buy |
+231
| New | +$80K | ﹤0.01% | 347 |
|